Decisions 2nd June 2015


At the meeting that took place on 2nd June, the folllowing decisions were agreed.

New Drug Requests

Approved

 

Tocilizumab monotherapy (TLS Red)

  • Approved for inclusion onto the formulary for adults with moderate/severe, active rheumatoid arthritis who cannot take methotrexate.

Abatacept subcutaneous (TLS Red)

  • Approved for inclusion onto the formulary for adults with moderate/severe, active rheumatoid arthritis, in combination with methotrexat, in accordance with NICE TAs 195 and 280.

Rituximab in combination with Leflunomide (TLS Red)

  • Approved for inclusion onto the formulary for adults with severe, active rheumatoid arthritis who cannot take methotrexate and who have had inadequate response or intolerance to other DMARDs and one or more anti-TNF therapies.


More information required

 

Simbrinza (Brinzolamide & Brimonidine)

  • Information regarding current prescribing trends and generic availability required

 

Other decisions


Wound Care Formularies

  • Each organisations version of the PAN AVON Wound care formulary is/will be included on the BNSSG Formulary Website.

 

Last updated by: on 01-10-2015 13:41